Investment Conference
Miami 2026 Edition

Venocare

Medical Device, Biotechnology

Venocare develops minimally invasive solutions for the treatment of chronic venous insufficiency and other vascular disorders. Its technology is designed to improve patient outcomes by enabling precise, efficient, and low-trauma interventions for vein-related conditions.

TriLogical

Technology, Information and Internet, Mobility, Deeptech

With over 25 years of IoT expertise in aviation, defense, HLS, and logistics, coupled with 15 years of specialized experience in the Railway industry, Trilogical Technologies is a prominent player in Remote Condition Monitoring, Diagnostics and Asset Management serving railroads, fleet owners, and shippers. Trilogical monitors thousands of mobile assets across extensive projects in the Middle East, Asia, and Africa. Our Control FREAK system for locomotives and multiple units allows realtime monitoring, diagnostics and smart analytical reporting enhancing operational and maintenance efficiency and increasing rolling stock’s availability, reliability & safety.

Remedy Cell

Biotechnology Research

Remedy Cell is a clinical-stage biopharmaceutical company advancing a novel class of cell-derived, cell-free therapies designed to address significant unmet needs in fibrotic diseases. The company’s lead program, RC-0315, is currently in a Phase 1b clinical trial for Idiopathic Pulmonary Fibrosis (IPF), a severe and underserved condition with limited therapeutic options. Backed by an experienced leadership team, world-class scientists, and globally recognized clinical and industry experts, Remedy Cell is positioned to deliver transformative therapies with the potential to redefine the standard of care across pulmonary fibrosis and broader fibrotic indications.

Omeza

Hospitals and Health Care

Omeza is a Florida-based medical technology company that specializes in the development and commercialization of advanced skin health and regenerative wound care therapies. The company transforms sustainably sourced marine by-products, such as cod liver oil and fish collagen, into its flagship product, Omeza Collagen Matrix (OCM™), which is the first FDA-cleared drug-device combination of its kind. They provide a non-surgical, outpatient-friendly solution for millions of patients suffering from chronic, hard-to-heal conditions like diabetic foot ulcers and venous leg ulcers. By utilizing bioactive marine science, Omeza offers a cost-effective alternative to expensive skin grafts that actively reduces biofilm and supports all phases of the natural healing process.

NAYA Therapeutics

Biotechnology Research

NAYA Therapeutics is a clinical-stage biotech developing next-generation bifunctional antibodies for cancer. Its proprietary plug-and-play platform enhances immune synapse formation for precise tumor killing. With lead programs in HCC and multiple myeloma, NAYA is advancing a differentiated pipeline including NY-303 (GPC3 x NKp46), NY- 500 (PD-1 x VEGF), and NY-338 (CD38 x NKp46), with clinical trials starting in 2025–2026.

Laser Team Medical

Medical Equipment Manufacturing, Medtech

Laser Team Medical Ltd is developing advanced medical laser systems built on its proprietary laser cavity technology. Its flagship innovation, a Nano-Thulium laser platform, enables highly precise, non-invasive skin treatments with minimal pain, reduced side effects, and short downtime - including applications in skin rejuvenation, wrinkle reduction, scar treatment, and other dermatological procedures. The technology is designed to safely treat a broader range of skin tones and conditions than many conventional laser systems, addressing an underserved segment of the dermatology and aesthetic device market. Laser Team Medical has secured patents and ongoing R&D support, including grants and incubator backing.